Meloxicam Teva (Meloxicam)

Meloxicam selectively blocks the COX‑2 enzyme, which limits the production of prostaglandins—chemicals that cause pain, swelling, and fever. By lowering prostaglandin levels, the drug provides anti‑inflammatory and analgesic effects while sparing COX‑1 activity that protects the stomach lining.

The appropriate dose of Meloxicam Teva is determined by the prescribing clinician based on the patient’s condition, severity, and overall health. Dosage may vary, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for meloxicam in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam offers a relatively selective COX‑2 inhibition, which may reduce gastrointestinal side effects compared with non‑selective NSAIDs such as ibuprofen or naproxen. However, individual response varies, and clinicians consider factors like cardiovascular risk, renal function, and patient tolerance when choosing an NSAID.

Meloxicam Teva tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Keep the product away from moisture, heat, and direct sunlight to maintain stability and potency throughout its shelf life.

Meloxicam Teva is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may help reduce occasional stomach discomfort. Patients should swallow the tablet whole and not crush or chew it.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions, liver injury, and renal impairment. Patients should report any signs of bleeding, severe abdominal pain, rash, or sudden swelling to their healthcare provider promptly.

Meloxicam Teva is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, active peptic ulcer disease, severe heart failure, and those who have had recent coronary artery bypass graft surgery. Caution is also advised for patients with impaired kidney or liver function.